Joerg Kumbrink
Vice-head, Research Associate (previously held)
University of Munich
Pathology
Molecular Pathology




Postdoctoral Associate (previously held)
Boston University Chobanian & Avedisian School of Medicine
Biochemistry & Cell Biology


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Meier-Schiesser B, Zecha C, Zierold S, Kolm I, Röckel M, Fröhlich W, Mittag N, Schmitt C, Kumbrink J, Hassel JC, Berking C, Nashan D, French LE, Vera-González J, Dummer R, Kerl-French K, Heinzerling L. Checkpoint inhibitor-induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level. JAAD Int. 2024 Jun; 15:157-164. PMID: 38882039; PMCID: PMC11180371; DOI: 10.1016/j.jdin.2023.11.013;
     
  2. Dewenter I, Kumbrink J, Poxleitner P, Smolka W, Liokatis P, Fliefel R, Otto S, Obermeier KT. New insights into redox-related risk factors and therapeutic targets in oral squamous cell carcinoma. Oral Oncol. 2023 Dec; 147:106573. PMID: 37951115
     
  3. Koehler VF, Achterfeld J, Sandner N, Koch C, Wiegmann JP, Ivanyi P, Käsmann L, Pusch R, Wolf D, Chirica M, Knösel T, Demes MC, Kumbrink J, Vogl TJ, Meyer G, Spitzweg C, Bojunga J, Kroiss M. NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer. J Cancer Res Clin Oncol. 2023 Nov; 149(15):14035-14043. PMID: 37548775; PMCID: PMC10590332; DOI: 10.1007/s00432-023-05134-x;
     
  4. Moser C, Jurinovic V, Sagebiel-Kohler S, Ksienzyk B, Batcha AMN, Dufour A, Schneider S, Rothenberg-Thurley M, Sauerland CM, Görlich D, Berdel WE, Krug U, Mansmann U, Hiddemann W, Braess J, Spiekermann K, Greif PA, Vosberg S, Metzeler KH, Kumbrink J, Herold T. A clinically applicable gene expression-based score predicts resistance to induction treatment in acute myeloid leukemia. Blood Adv. 2021 11 23; 5(22):4752-4761. PMID: 34535016; PMCID: PMC8759116; DOI: 10.1182/bloodadvances.2021004814;
     
  5. Sultova E, Westphalen CB, Jung A, Kumbrink J, Kirchner T, Mayr D, Rudelius M, Ormanns S, Heinemann V, Metzeler KH, Greif PA, Hester A, Mahner S, Harbeck N, Wuerstlein R. Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting. Diagnostics (Basel). 2021 Apr 20; 11(4). PMID: 33924134; PMCID: PMC8074310; DOI: 10.3390/diagnostics11040733;
     
  6. Sultova E, Westphalen CB, Jung A, Kumbrink J, Kirchner T, Mayr D, Rudelius M, Ormanns S, Heinemann V, Metzeler KH, Greif PA, Burges A, Trillsch F, Mahner S, Harbeck N, Wuerstlein R. NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU. Arch Gynecol Obstet. 2021 05; 303(5):1331-1345. PMID: 33277683; PMCID: PMC8053190; DOI: 10.1007/s00404-020-05881-z;
     
  7. Guenther M, Veninga V, Kumbrink J, Haas M, Westphalen CB, Kruger S, Heinemann V, Kirchner T, Boeck S, Jung A, Ormanns S. POLE gene hotspot mutations in advanced pancreatic cancer. J Cancer Res Clin Oncol. 2018 Nov; 144(11):2161-2166. PMID: 30194485
     
  8. Kumbrink J, de la Cueva A, Soni S, Sailer N, Kirsch KH. A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo. Tumour Biol. 2016 Aug; 37(8):10665-73.View Related Profiles. PMID: 26867768; DOI: 10.1007/s13277-016-4902-8;
     
  9. Rouka E, Simister PC, Janning M, Kumbrink J, Konstantinou T, Muniz JR, Joshi D, O'Reilly N, Volkmer R, Ritter B, Knapp S, von Delft F, Kirsch KH, Feller SM. Differential Recognition Preferences of the Three Src Homology 3 (SH3) Domains from the Adaptor CD2-associated Protein (CD2AP) and Direct Association with Ras and Rab Interactor 3 (RIN3). J Biol Chem. 2015 Oct 16; 290(42):25275-92.View Related Profiles. PMID: 26296892; PMCID: PMC4646179; DOI: 10.1074/jbc.M115.637207;
     
  10. Kumbrink J, Soni S, Laumbacher B, Loesch B, Kirsch KH. Identification of Novel Crk-associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities. J Biol Chem. 2015 May 8; 290(19):12247-55.View Related Profiles. PMID: 25805500; PMCID: PMC4424356; DOI: 10.1074/jbc.M115.649947;
     
Showing 10 of 17 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 17 publications over 12 distinct years, with a maximum of 2 publications in 2012 and 2013 and 2015 and 2021 and 2023

YearPublications
20051
20101
20111
20122
20132
20152
20161
20181
20201
20212
20232
20241

Contact for Mentoring:

72 E. Concord St Silvio Conte (K)
Boston MA 02118
Google Map

617.638.4342
Download vCard

Kumbrink's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (140) concept(s)
_
Co-Authors
See all (6) people
_
Similar People
See all (60) people
_